Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

The validity of shortened multiple-breath washout testing using sulfur hexafluoride in the assessment of patients with COPD

Enya Daynes, Neil Greening, John Owers-Bradley, Sally J. Singh, Salman Siddiqui
ERJ Open Research 2021 7: 00379-2020; DOI: 10.1183/23120541.00379-2020
Enya Daynes
1Centre of Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre – Respiratory, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Enya Daynes
  • For correspondence: enya.daynes@uhl-tr.nhs.uk
Neil Greening
1Centre of Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre – Respiratory, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Owers-Bradley
2School of Physics and Astronomy, University of Nottingham, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally J. Singh
1Centre of Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre – Respiratory, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salman Siddiqui
3NIHR Leicester Biomedical Research Centre – Respiratory, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Bland–Altman plots for lung clearance index (LCI)1/40th and LCI1/20th within and between visits. Bland–Altman plots for LCI1/40th within visit repeatability, LCI1/20th within visit repeatability, LCI1/40th between visit (8 week) repeatability and LCI1/20th between visit (8 week) repeatability. LoA: limits of agreement 95% confidence interval.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Correlations between lung clearance index (LCI)1/20th and LCI1/40th washout test. Correlations between lung clearance index and 1/40th and 1/20th washout concentrations. Plotted with a line of best fit and the confidence intervals (dotted line).

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Correlations between forced expiratory volume in 1 s (FEV1) % predicted and a) lung clearance index (LCI)1/20th, b) LCI1/40th, c) Scond conducting zone and d) Sacin acinar zone. Correlations between measures of multiple-breath washout and forced expiratory volume in 1 s per cent predicted (FEV1 %). GOLD: Global Initiative for Chronic Obstructive Lung Disease.

Tables

  • Figures
  • TABLE 1

    Clinical characteristics of study populations

    All subjectsRepeatability cohort
    Subjects n8420
    Gender male:female62:2215:5
    Age years70±7.369±7
    FEV1 % predicted51±1750±15
    FEV1 L1.36±0.531.35±0.43
    FVC L2.70±0.862.57±0.55
    FEV1/FVC ratio0.49±0.130.52±0.13
    GOLD spirometry stageGOLD 1: 2GOLD 1: 0
    GOLD 2–3: 69GOLD 2–3: 17
    GOLD 4: 13GOLD 4:3
    CAT score18.64±7.4821.14±7.15
    mMRC score2.85±0.832.93±0.75
    BMI kg·m−229±729±7
    Smoker current:ex9:751:19

    Baseline characteristics presented as mean±sd unless otherwise stated. n=20. FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; GOLD: Global Initiative for Chronic Obstructive Lung Disease; CAT score: COPD Assessment Test score; mMRC: Modified Medical Research Council Dyspnoea Score; BMI: body mass index.

    • TABLE 2

      Intraclass correlation coefficients for within and between visit measures of the lung clearance index

      Mean±sd V1Mean±sd V2Within visit ICC 20 minMean±sd V3 (between visit)Between visit ICC 8 weeks
      FEV11.36±0.471.42±0.461.35±0.430.92
      FEV1 %51.45±14.8652.94±16.7152.94±16.710.92
      FEF25–750.58±0.360.62±0.260.62±0.260.64
      FVC L2.58±0.632.86±0.732.57±0.550.74
      LCI1/40th11.24±2.2511.11±1.900.9211.42±2.030.88
      FRC1/40th L3.51±1.113.19±0.930.963.50±0.890.92
      Scond0.06±0.110.06±0.150.940.04±0.030.52
      Sacin0.784±0.460.84±0.590.950.698±0.400.80
      LCIds1.29±0.361.27±0.210.471.43±0.380.05
      LCIvent1.54±0.311.50±0.250.801.51±0.200.10
      LCI1/20th8.59±1.438.40±1.270.968.53±1.180.80
      FRC1/20th L3.40±1.053.55±1.010.903.38±1.010.91

      n=19. Intraclass correlation coefficient (ICC) measured by Pearson's correlation coefficient. FEV1: forced expiratory volume in 1 s; FEF25–75: forced expiratory flow at at 25–75% of FVC; FVC: forced vital capacity; LCI: lung clearance index; FRC: functional residual capacity; Scond: convection-dependent ventilation heterogeneity, Sacin: diffusion-convection-dependent ventilation heterogeneity. 1/40th=FRC or LCI calculated at traditional stopping point. 1/20th=FRC or LCI calculated at truncated stopping point of 1/20th of the end tidal wash-in concentration over three consecutive breaths.

      • TABLE 3

        Sample size calculation for within and between visit (V) study designs

        Change in LCIWithin visit limits of agreement (V2-V1)Between visit limits of agreement (V3-V1)
        80% power90% power80% power90% power
        2.415191216
        2.612161013
        2.81114912
        3.0912810

        Estimated sample size calculation using an absolute change in lung clearance index (LCI)1/40th and the within- and between-visit limits of agreement at 80% and 90% power.

        • TABLE 4

          One-way ANOVA for COPD GOLD staging

          GOLD 1GOLD 2GOLD 3GOLD 4p-value
          Subjects n2382514
          LCI1/20th7.898.14±1.02*8.08±1.159.35±1.19*<0.01
          LCI1/40th10.0110.46±1.6*11.03±2.2412.25±2.47*0.05
          Scond0.020.06±0.090.06±0.11−0.01±0.140.31
          Sacin0.400.35±0.280.46±0.370.61±0.410.16

          One-Way ANOVA stratified by disease severity according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometry strata. LCI: lung clearance index; Scond: conducting zone; Sacin: acinar zone. *: post hoc tests (Tukey's) between GOLD staging p<0.05.

          • TABLE 5

            Univariate correlation of LCI1/20th and physiological indices

            LCI1/20thLCI1/40th
            LCI1/20th0.76**
            LCI1/40th0.76**
            FEV1 % predicted−0.40**−0.25*
            FVC % predicted−0.11−0.61
            FEF25–75−0.43−0.36
            Scond−0.19−0.07
            Sacin0.220.11

            N=80. Pearson's correlation coefficient of lung clearance index (LCI), forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), forced expiratory flow at at 25–75% of FVC (FEF25–75), and Phase III analysis of the conducting zone (Scond) and acinar zone (Sacin). *p<0.05; **p<0.01.

            PreviousNext
            Back to top
            Vol 7 Issue 3 Table of Contents
            ERJ Open Research: 7 (3)
            • Table of Contents
            • Index by author
            Email

            Thank you for your interest in spreading the word on European Respiratory Society .

            NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

            Enter multiple addresses on separate lines or separate them with commas.
            The validity of shortened multiple-breath washout testing using sulfur hexafluoride in the assessment of patients with COPD
            (Your Name) has sent you a message from European Respiratory Society
            (Your Name) thought you would like to see the European Respiratory Society web site.
            CAPTCHA
            This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
            Print
            Citation Tools
            The validity of shortened multiple-breath washout testing using sulfur hexafluoride in the assessment of patients with COPD
            Enya Daynes, Neil Greening, John Owers-Bradley, Sally J. Singh, Salman Siddiqui
            ERJ Open Research Jul 2021, 7 (3) 00379-2020; DOI: 10.1183/23120541.00379-2020

            Citation Manager Formats

            • BibTeX
            • Bookends
            • EasyBib
            • EndNote (tagged)
            • EndNote 8 (xml)
            • Medlars
            • Mendeley
            • Papers
            • RefWorks Tagged
            • Ref Manager
            • RIS
            • Zotero
            Share
            The validity of shortened multiple-breath washout testing using sulfur hexafluoride in the assessment of patients with COPD
            Enya Daynes, Neil Greening, John Owers-Bradley, Sally J. Singh, Salman Siddiqui
            ERJ Open Research Jul 2021, 7 (3) 00379-2020; DOI: 10.1183/23120541.00379-2020
            del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
            Full Text (PDF)

            Jump To

            • Article
              • Abstract
              • Abstract
              • Introduction
              • Methods
              • Results
              • Discussion
              • Footnotes
              • References
            • Figures & Data
            • Info & Metrics
            • PDF

            Subjects

            • COPD and smoking
            • Lung structure and function
            • Tweet Widget
            • Facebook Like
            • Google Plus One

            More in this TOC Section

            Original research articles

            • Effects of bepotastine
            • Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
            • Tozorakimab in patients hospitalised with COVID-19
            Show more Original research articles

            COPD

            • Effects of bepotastine
            • Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
            • Tozorakimab in patients hospitalised with COVID-19
            Show more COPD

            Related Articles

            Navigate

            • Home
            • Current issue
            • Archive

            About ERJ Open Research

            • Editorial board
            • Journal information
            • Press
            • Permissions and reprints
            • Advertising

            The European Respiratory Society

            • Society home
            • myERS
            • Privacy policy
            • Accessibility

            ERS publications

            • European Respiratory Journal
            • ERJ Open Research
            • European Respiratory Review
            • Breathe
            • ERS books online
            • ERS Bookshop

            Help

            • Feedback

            For authors

            • Instructions for authors
            • Publication ethics and malpractice
            • Submit a manuscript

            For readers

            • Alerts
            • Subjects
            • RSS

            Subscriptions

            • Accessing the ERS publications

            Contact us

            European Respiratory Society
            442 Glossop Road
            Sheffield S10 2PX
            United Kingdom
            Tel: +44 114 2672860
            Email: journals@ersnet.org

            ISSN

            Online ISSN: 2312-0541

            Copyright © 2023 by the European Respiratory Society